Genomics Medicine Ireland Ltd.

Industry

  • Pharmaceuticals
  • In Vitro Diagnostics
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
    • Drug Discovery Technologies
      • Genomics-Proteomics
  • Research, Analytical Equipment & Supplies
See more in Biomedtracker

Latest on Genomics Medicine Ireland Ltd.

Scrip

Deal Watch: Boehringer Teams Up In CNS Disorders Again, This Time With Domain

 
• By Joseph Haas, Alex Shimmings, John Davis, Jessica Merrill, Jo Shorthouse, and Eleanor Malone

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Boehringer Ingelheim Taps In

In Vivo

Device/Diagnostics Quarterly Deal-Making Statistics, Q2 2017

 
• By Amanda Micklus and Maureen Riordan

Device Transactions Continuing the downward trend in financing over the past several quarters, the device industry collected $1.2 billion in Q2 funding, a 48% decrease from Q1's $2.3 billion total. It

In Vivo

Deals Shaping The Medical Industry, February 2017

 
• By Steven Muntner, Amanda Micklus, Beth Allan, Maureen Riordan, and Deanna Kamienski

IN VITRO DIAGNOSTICS Mergers & Acquisitions PerkinElmer Inc. Tulip Diagnostics Pvt. Ltd. PerkinElmer Inc. is acquiring Indian firm Tulip Diagnostics Pvt. Ltd. (Jan.) Tulip focuses on assay sys

Scrip

Deal Watch: More Predictions 2017 Will Be A Banner Year For Deal-Making

 
• By Joseph Haas and Ying Huang

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Jan. 9-24. Deal Watc